IL-10-producing and naturally occurring CD4+Tregs: Limiting collateral damage

Journal of Clinical Investigation

Volumn 114, Issue 10, 2004, Pages 1372-1378

  O'Garra, Anne ^a   Vieira, Pedro L ^a   Vieira, Paulo ^b   Goldfeld, Anne E ^c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b U du Devmt des Lymphocytes   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

ANTIGEN PRESENTING CELL; CELL FUNCTION; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNITY, NATURAL; INFECTION; INFLAMMATION; INTERLEUKIN-10; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

EID: 85047692430     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23215     Document Type: Review

References (105)

1. Sundstedt, A., et al. 1997. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J. Immunol. 158:180-186.
2. Sundstedt, A., O'Neill, E.J., Nicolson, K.S., and Wraith, D.C. 2003. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170:1240-1248.
3. Groux, H., et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
4. Roncarolo, M.G., Bacchetta, R., Bordignon, C., Narula, S., and Levings, M.K. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68-79.
5. Buer, J., et al. 1998. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187:177-183.
6. Barrat, F.J., et al. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603-616.
7. Pontoux, C., Banz, A., and Papiernik, M. 2002. Natural CD4CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Int. Immunol. 14:233-239.
8. Vieira, P.L., et al. 2004. IL-10 secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occuring CD4+CD25+ regulatory T cells. J. Immunol. 172:5986-5993.
9. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
10. Sakaguchi, S., et al. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
11. Shevach, E.M. 2000. Suppressor T cells: Rebirth, function and homeostasis. Curr. Biol. 10:R572-R575.
12. Shevach, E.M. 2002. CD4+CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
13. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
14. Hori, S., Nomura, T., and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
15. Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
16. Ramsdell, F. 2003. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity. 19:165-168.
17. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L., and Powrie, F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1004.
18. Liu, H., Hu, B., Xu, D., and Liew, F.Y. 2003. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J. Immunol. 171:5012-5017.
19. Boussiotis, V.A., et al. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105:1317-1325.
20. Aandahl, E.M., Michaelsson, J., Moretto, W.J., Hecht, P.M., and Nixon, D.F. 2004. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459.
21. Kinter, A.L., et al. 2004. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4 and CD8 HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
22. Oswald-Richter, K., et al. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2:E198.
23. Xu, D., et al. 2003. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170:394-399.
24. Sher, A., and Coffman, R.L. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
25. O'Garra, A., and Robinson, D. 2004. Development and function of T helper 1 cells. Adv. Immunol. 83:133-162.
26. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275-283.
27. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
28. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., and Anderton, S.M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950.
29. McGuirk, P., McCann, C., and Mills, K.H. 2002 Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
30. Edwards, A.D., et al. 2002. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169:3652-3660.
31. Ohno, S., Epplen, J.T., Matsunaga, T., and Hozumi, T. 1981. The curse of Prometheus is laid upon the immune system. Prog. Allergy. 28:8-39.
32. O'Garra, A., Steinman, L., and Gijbels, K. 1997. CD4+ T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9:872-883.
33. Jenkins, M.K., et al. 1991. Induction and maintenance of anergy in mature T cells. Adv. Exp. Med. Biol. 292:167-176.
34. Powrie, F., Correa-Oliveira, R., Mauze, S., and Coffman, R.L. 1994. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589-600.
35. Maloy, K.J., and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816-822.
36. Cobbold, S.P., Graca, L., Lin, C.Y., Adams, E., and Waldmann, H. 2003. Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance. Transpl. Int. 16:66-75.
37. Read, S., Malmstrom, V., and Powrie, F. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
38. Takahashi, T., et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxitic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
39. Seddon, B., and Mason, D. 1999. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor b and interleukin 4 in the prevention of autoimmune thryroiditis in rats by peripheral CD4+ CD45RC- cells and CD4+ CD8-thymocytes. J. Exp. Med. 189:279-288.
40. Powrie, F., Carlino, J., Leach, M.W., Mauze, S., and Coffman, R.L. 1996. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183:2669-2674.
41. Nakamura, K., Kitani, A., and Strober, W. 2001 Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J. Exp. Med. 194:629-644.
42. Green, E.A., Gorelik, L., McGregor, C.M., Tran, E.H., and Flavell, R.A. 2003. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 100:10878-10883.
43. Oida, T., et al. 2003. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J. Immunol. 170:2516-2522.
44. Akbari, O., et al. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024-1032.
45. Weiner, H.L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:335-343.
46. Abbas, A.K., Murphy, K.M., and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
47. Fitch, F.W., McKisic, M.D., Lancki, D.W., and Gajewski, T.F. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29-48.
48. Szabo, S., Dighe, A.S., Gubler, U., and Murphy, K.M. 1997. Regulation of the interleukin (IL)-12β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-824.
49. Rogge, L., et al. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
50. Murphy, K.M., et al. 2000. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18:451-494.
51. Szabo, S.J., et al. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:655-669.
52. Locksley, R.M., and Scott, P. 1991. Helper T-cell subsets in mouse leishmaniasis:induction, expansion and effector function. Immunol. Today. 12:58-61.
53. Paul, W.E., and Seder, R.A. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
54. Powrie, F., and Coffman, R.L. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today. 14:270-274.
55. Lafaille, J.J., et al. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease. J. Exp. Med. 186:307-312.
56. Pakala, S.V., Kurrer, M.O., and Katz, J.D. 1997. T helper 2 (Th2) cells induce acute pancreatitis amd diabetes in immune-compromised non-obese diabetic (NOD) mice. J. Exp. Med. 186:299-306.
57. Terabe, M., et al. 2003. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198:1741-1752.
58. Terabe, M., Park, J.M., and Berzofsky, J.A. 2004. Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol. Immunother. 53:79-85.
59. Blaser, K., and Akdis, C.A. 2004. Interleukin-10, T regulatory cells and specific allergy treatment. Clin. Exp. Allergy. 34:328-331.
60. Akdis, C.A., and Blaser, K. 2001. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. 3:891-898.
61. O'Garra, A., and Vieira, P. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10:801-805.
62. O'Garra, A., and Vieira, P. 2003. Twenty-first century Foxp3. Nat. Immunol. 4:304-306.
63. Trinchieri, G. 2001. Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J. Exp. Med. 194:F53-F57.
64. Li, C., Corraliza, I., and Langhorne, J. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67:4435-4442.
65. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. 1993. Interleukin-10 deficient mice develop chronic enterocolitis. Cell. 75:263-274.
66. Tanchot, C., et al. 1998. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. Immunity. 8:581-590.
67. Gilliet, M., and Liu, Y.J. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:695-704.
68. Salgame, P., et al. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 254:279-282.
69. Gazzinelli, R.T., Oswald, I.P., James, S.L., and Sher, A. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792-1796.
70. Hunter, C.A., et al. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:3311-3316.
71. Kullberg, M.C., et al. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66:5157-5166.
72. Maloy, K.J., et al. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-119.
73. Carvalho, E.M., Barral, A., Costa, J.M., Bittencourt, A., and Marsden, P. 1994. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop. 56:315-325.
74. Mahanty, S., et al. 1997. Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect. Immun. 65:1742-1747.
75. King, C.L., et al. 1996. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J. Immunol. 156:4715-4721.
76. Sieling, P.A., et al. 1993. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J. Immunol. 150:5501-5510.
77. Gong, J.H., et al. 1996. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 64:913-918.
78. Gerosa, F., et al. 1999. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92:224-234.
79. Delgado, J.C., et al. 2002. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc. Natl. Acad. Sci. U. S. A. 99:7576-7581.
80. Ranjbar, S., Ly, N., Thim, S., Reynes, J.M., and Goldfeld, A.E. 2004. Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels. J. Immunol. 172:1953-1959.
81. Silva, RA, Pais, T.F., and Appelberg, R. 2001. Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination. J. Immunol. 167:1535-1541.
82. Kane, M.M., and Mosser, D.M. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
83. Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M., and Sacks, D.L. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
84. Murray, H.W., et al. 2002. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70:6284-6293.
85. Tripp, C.S., Kanagawa, O., and Unanue, E.R. 1995. Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12. J. Immunol. 155:3427-3432.
86. Keane, J., et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
87. Flynn, J.L., and Chan, J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
88. Smith, S., et al. 2002. Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect. Immun. 70:2082-2089.
89. Fenhalls, G., et al. 2002. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Inject. Immun. 70:6330-6338.
90. Tsenova, L., Bergtold, A., Freedman, V.H., Young, R.A., and Kaplan, G. 1999. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 96:5657-5662.
91. 2002. Joint United Nations Programme on HIV/ AIDS (UNAIDS). Report on the global HIV/AIDS epidemic 2002. UNAIDS/02.26E. http://www. unaids.org.
92. Belkaid, Y., et al. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
93. Kullberg, M.C., et al. 2002. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196:505-515.
94. Suri-Payer, E., and Cantor, H. 2001. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J. Autoimmun. 16:115-123.
95. Grohmann, U., Fallarino, F., and Puccetti, P. 2003. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24:296-297.
96. Munn, D.H., and Mellor, A.L. 2004. IDO and tolerance to tumors. Trends Mol. Med. 10:15-18.
97. Annacker, O., et al. 2001. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008-3018.
98. Mosmann, T.R., and Coffman, R.L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
99. Castro, A.G., et al. 2000. Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide. J. Exp. Med. 192:1529-1534.
100. Thornton, A.M., and Shevach, E.M. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
101. Janeway, C.A., Jr., and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
102. Steinman, R.M., Hawiger, D., and Nussenzweig, M.C. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
103. Goldfeld, A., Doyle, C, and Maniatis, T. 1990. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 87:9769-9773.
104. Goldfeld, A.E., and Maniatis, T. 1989. Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes. Proc. Natl. Acad. Sci. U. S. A. 86:1490-1494.
105. Sharpe, A.H. 1995. Analysis of lymphocyte costimulation in vivo using transgenic and 'knock-out' mice. Curr. Opin. Immunol. 7:389-395.